Artiphishell VulnOps Platform is a commercial vulnerability assessment solution by Artiphishell. Mana Security is a free vulnerability assessment solution. Features, integrations, deployment and the company behind each one, side by side.
Vuln ops platform that deduplicates, validates, prioritizes, and remediates findings.
Mana Security is a macOS-focused vulnerability management tool that continuously monitors 100+ applications for security vulnerabilities and tracks patching performance against community benchmarks.
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
Artiphishell VulnOps Platform fits if you are an enterprise.
Mana Security fits if you are a startup, you need a free product and you want an open-source product.
Common questions when comparing Artiphishell VulnOps Platform vs Mana Security for vulnerability assessment.
Artiphishell VulnOps Platform: Vuln ops platform that deduplicates, validates, prioritizes, and remediates findings, built by Artiphishell.
Mana Security: Mana Security is a macOS-focused vulnerability management tool that continuously monitors 100+ applications for security vulnerabilities and tracks patching performance against community benchmarks.
The table above shows where their features, integrations, deployment and company size fit differ.
Artiphishell VulnOps Platform is made by Artiphishell. Mana Security is open-source with 27 GitHub stars. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. Artiphishell VulnOps Platform and Mana Security are both Vulnerability Assessment products, and both cover CVE. Key differences: Artiphishell VulnOps Platform is Commercial while Mana Security is Free, Mana Security is open-source. Use the table above to see where features, deployment and company size fit differ.
No Vulnerability Assessment shortlist yet. This is the closest one.
Updated 2026-11-01
See the shortlist
